Respiratory

DC 6817

Pulmonary Vascular Disease

Educational use only. Not legal or medical advice. Read 38 CFR §4.97 on eCFR
Diagnostic Code
6817
CFR Section
§4.97 — Respiratory

Rating Tiers

100%

Primary pulmonary hypertension, or; chronic pulmonary thromboembolism with evidence of pulmonary hypertension, ventricular hypertrophy, or cor pulmonale, or; pulmonary hypertension secondary to other obstructive disease of pulmonary arteries or veins with evidence of ventricular hypertrophy or cor pulmonale

60%

Chronic pulmonary thromboembolism requiring anticoagulant therapy, or; following inferior vena cava surgery without evidence of pulmonary hypertension or ventricular dysfunction

30%

Symptomatic, following resolution of acute pulmonary embolism

0%

Asymptomatic, following resolution of pulmonary thromboembolism

Rated Under Formula

This condition is rated using the §4.97 general rating formula.

What Raters Look For

Based on M21-1 adjudication criteria for Respiratory conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.B
  • •Pulmonary function test results: FEV1 (% of predicted), FVC, FEV1/FVC ratio, and DLCO
  • •Exercise tolerance in METs (metabolic equivalents) if cardiac limitation is also relevant
  • •Frequency of exacerbations requiring medical visits, oral steroids, or hospitalization
  • •Oxygen therapy use — whether prescribed and under what conditions
  • •Sleep study results and AHI score if sleep apnea is claimed
  • •Medication regimen: inhalers, systemic steroids, biologics
  • •Smoking history (noted but not used to reduce rating)
NoteFor sleep apnea, raters look specifically at whether a CPAP/BiPAP is required — that alone meets the 50% rating criteria under DC 6847.